Literature DB >> 16816927

Abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage with Kashin-Beck disease.

Xiong Guo1, Hong Zuo, Chun-Xia Cao, Yan Zhang, Dong Geng, Zeng-Tie Zhang, Yin-Gang Zhang, Klaus von der Mark, Helga von der Mark.   

Abstract

The purpose of the current study was to investigate the abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage from patients with Kashin-Beck disease (KBD) to understand the pathogenesis of chondronecrosis in KBD. Articular cartilage and growth plate cartilage collected were divided into four groups: control children (8 samples, 5 cases), KBD children (19 samples, 9 cases), control adults (8 samples, 6 cases), and KBD adults (16 samples, 15 cases). The presence of PTHrP, TGF-beta1, bFGF, VEGF, and collagen X in articular cartilage and in growth plate cartilage was analyzed by immunohistochemistry. Articular cartilage and growth plate were each divided in three zones, and the rate of positive cells was counted by light microscope for cytoplasmic and pericellular staining. Results showed that (1) in KBD children, Col X expression was lower in the deep zone of growth plate cartilage than in normal children; in articular cartilage of KBD adults, however, collagen X expression was higher in the middle zone compared to the controls; (2) staining for bFGF, PTHrP, TGF-beta1, and VEGF in KBD adult patients was prominent in the chondrocyte clusters and the eroded surface of articular cartilage, and the percentage of chondrocyte staining was significantly higher than in control samples (t = 3.64-10.34, df = 12 for children and 19 for adults, P = 0.002-0.0001); and (3) the enhanced PTHrP, TGF-beta1, and VEGF staining in the deep and middle zone of KBD articular cartilage correlated with the high incidence of chondronecrosis in the middle zone (48.5% +/- 10.2%) and deep zone (70.6% +/- 27.0%) of adult KBD cartilage. In conclusion, Col X expression was reduced in areas of chondrocyte necrosis in the deep zone of KBD articular cartilage, indicating changes in terminal chondrocyte differentiation. PTHrP, TGF-beta1, and VEGF expression was significantly altered and indicated degenerative changes in KBD cartilage, which initially resemble those occurring in osteoarthritis, but lead eventually to chondronecrosis, an event not observed in osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816927     DOI: 10.1007/s00774-006-0690-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.976


  40 in total

Review 1.  Developmental regulation of the growth plate.

Authors:  Henry M Kronenberg
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 2.  TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties.

Authors:  J Massagué; S Cheifetz; F T Boyd; J L Andres
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation.

Authors:  Y Kato; M Iwamoto
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

4.  [A study on abnormal chondrocyte differentiation and abnormal expression of collagen types in articular cartilage from patients with Kaschin-Beck disease].

Authors:  X Guo; A Thomas; L Pirkko
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1998-02

Review 5.  Vascular endothelial growth factor and its receptors.

Authors:  M Klagsbrun; P A D'Amore
Journal:  Cytokine Growth Factor Rev       Date:  1996-10       Impact factor: 7.638

6.  Transforming growth factor-beta (TGF-beta) and articular chondrocytes.

Authors:  J P Pujol; P Galera; S Pronost; K Boumediene; D Vivien; M Macro; W Min; F Redini; H Penfornis; M Daireaux
Journal:  Ann Endocrinol (Paris)       Date:  1994       Impact factor: 2.478

7.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

Authors:  A C Karaplis; A Luz; J Glowacki; R T Bronson; V L Tybulewicz; H M Kronenberg; R C Mulligan
Journal:  Genes Dev       Date:  1994-02-01       Impact factor: 11.361

8.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.

Authors:  M A Anzano; A B Roberts; J M Smith; M B Sporn; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.

Authors:  R Shiang; L M Thompson; Y Z Zhu; D M Church; T J Fielder; M Bocian; S T Winokur; J J Wasmuth
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

10.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.

Authors:  M E Joyce; A B Roberts; M B Sporn; M E Bolander
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  28 in total

Review 1.  Cartilage cell clusters.

Authors:  Martin K Lotz; Shuhei Otsuki; Shawn P Grogan; Robert Sah; Robert Terkeltaub; Darryl D'Lima
Journal:  Arthritis Rheum       Date:  2010-08

2.  Detection of serum proteomic changes and discovery of serum biomarkers for Kashin-Beck disease using surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS).

Authors:  Shuang Wang; Xiong Guo; Wu-Hong Tan; Dong Geng; Bi-Ping Deng; Chun-e Wang; Xun Qu
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 3.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

4.  Exome sequencing identified FGF12 as a novel candidate gene for Kashin-Beck disease.

Authors:  Feng Zhang; Lanlan Dai; Weimin Lin; Wenyu Wang; Xuanzhu Liu; Jianguo Zhang; Tielin Yang; Xiaogang Liu; Hui Shen; Xiangding Chen; Lijun Tan; Qing Tian; Hong-Wen Deng; Xun Xu; Xiong Guo
Journal:  Funct Integr Genomics       Date:  2015-08-20       Impact factor: 3.410

5.  The integrative analysis of DNA methylation and mRNA expression profiles confirmed the role of selenocompound metabolism pathway in Kashin-Beck disease.

Authors:  Ping Li; Yujie Ning; Weizhuo Wang; Xiong Guo; Blandine Poulet; Xi Wang; Yan Wen; Jing Han; Jingcan Hao; Xiao Liang; Li Liu; Yanan Du; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Cuiyan Wu; Sen Wang; Hongmou Zhao; Guanghui Zhao; Mary B Goldring; Feng Zhang; Peng Xu
Journal:  Cell Cycle       Date:  2020-08-20       Impact factor: 4.534

6.  Expression and localization of the small proteoglycans decorin and biglycan in articular cartilage of Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency.

Authors:  Mengying Wang; Senhai Xue; Qian Fang; Meng Zhang; Ying He; Ying Zhang; Mikko J Lammi; Junling Cao; Jinghong Chen
Journal:  Glycoconj J       Date:  2019-09-02       Impact factor: 2.916

Review 7.  Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretations.

Authors:  Jing Han; Weizhuo Wang; Chengjuan Qu; Ruiyu Liu; Wenrong Li; Zongqiang Gao; Xiong Guo
Journal:  Inflamm Res       Date:  2015-08-11       Impact factor: 4.575

8.  Expression of immunoregulatory tumor necrosis factor-like molecule TL1A in chicken chondrocyte differentiation.

Authors:  Vilmos Tubak; Erika Határvölgyi; László Krenács; Eva Korpos; Erzsébet Kúsz; Ernõ Duda; Eva Monostori; Tibor Rauch
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

9.  Expression profile analysis of mycotoxin-related genes in cartilage with endemic osteochondropathy Kashin-Beck Disease.

Authors:  Feng Zhang; Xiong Guo; Weizhuo Wang; Shixun Wu; Weijuan Ma; Hua Yan
Journal:  BMC Musculoskelet Disord       Date:  2012-07-24       Impact factor: 2.362

10.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.